ArticleInvestigational new drugs2018

A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors.

Hideki Ueno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.